Brief: Arctic Bioscience Q4 Sales Revenues Rise To NOK 10.6 Mln
Feb 9 (Reuters) - Arctic Bioscience AS ABSA.OL :
* Q4 TOTAL SALES REVENUES MORE THAN DOUBLED IN Q4 2022 (NOK
10,6
MILLION) COMPARED TO Q4 2021 (NOK 4,8 MILLION)
* Q4 EBITDA: NOK -11,4 MILLION (NOK -11,8 MILLION)
* Q4 GROSS PROFIT: NOK 4,7 MILLION (NOK 1,2 MILLION)
Source text for Eikon: ID:nWkr8HBHDq
Further company coverage: ABSA.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Arctic Bioscience AS
See all newsNorway's Arctic Bioscience Q1 sales rise 78% to record on America boost
Brief: Arctic Bioscience Q1 Adjusted EBITDA NOK -6.5 Million
Norway's Arctic Bioscience 2025 revenue falls due to product recall impact
Brief: Arctic Bioscience Q3 Adjusted EBITDA NOK -7.8 Million
Brief: Arctic Bioscience H1 Adjusted EBITDA NOK -13.6 Million